Your doctor probably will also want to check your eGFR if you have a condition that affects your kidneys, such as certainautoimmune disorders, diabetes, high blood pressure, heart disease,frequent urinary tract infections, or a history of smoking. You may also get an eGFR test if other people...
Stage 3a & 3b CKD: Mild to severe loss of kidney function, eGFR 30-59. Stage 4 CKD: Severe loss of kidney function, eG FR 15-29. Is GFR 94 normal? Results. A GFR of60 or higher is in the normal range. A GFR below 60 may mean kidney disease. A GFR of 15 or lower may mean...
What does this mean for applications of AI in drug discovery? AI can, in principle, deliver all of the above aims: it can make decisions faster (predictions are faster than experiments) and more cheaply (predictions cost less than experiments), and lead to better decisions (where suitable dat...
声明: 本网站大部分资源来源于用户创建编辑，上传，机构合作，自有兼职答题团队，如有侵犯了你的权益，请发送邮箱到feedback@deepthink.net.cn 本网站将在三个工作日内移除相关内容,刷刷题对内容所造成的任何后果不承担法律上的任何义务或责任
Hemodialysis is an independent risk factor for the development of both de novo and recurrent heart failure, with a 2-year mortality after a diagnosis of congestive heart failure as high as 51% [37]. Classical complicated atherosclerotic disease does not appear to be the predominant mode of ...
However, there is always a trade-off between the radiation dose and image quality and the contrast dose (potentially nephrotoxic) is relatively high, resulting in a limited use of CT for repeated scanning. The commonly used parameters include: BF, BV, MTT (mean transit time) and permeability...
[3,58,85]. This does not mean, however, that muscle mass should be of less importance when assessing nutritional status, but rather that measurements of muscle strength, that can be easily assessed by HGS, should be incorporated as an important component for the diagnosis of muscle ...
EGFR_TK indicates epidermal growth factor receptor tyrosine kinase. Our expanding knowledge of biomarkers and the interconnections among them is enabling development of more complex tests sometimes embedded into algorithms. Specific diseases, such as non-small cell lung cancer now have multiple tests avai...
It is currently the second leading cause of cancer-related mortality in women aged 0–39 worldwide, with 44,800 deaths per year. In Canada, approximately 1 in 200 women develop breast cancer by the age of 40 years, with a cumulative risk of breast cancer before 40 years of 0.61%, ...
Linares Díaz, Julio, John Edwards, Anne-Leen Deleu, Niccolo Giaj-Levra, Elena Prisciandaro, Benoit Roch, Marianne Paesmans, Thierry Berghmans, and Mariana Brandão. 2024. "What Does N2 Lymph Node Involvement Mean for Patients with Non-Small Cell Lung Cancer (NSCLC)?—A Review of Implicat...